Global Pharmacovigilance and Drug Safety Software Market Size Study by Functionality, by Delivery Mode (On Premise & On Demand/Cloud based), by End User & by Region - Global Forecast 2018- 2025

    Global Pharmacovigilance and Drug Safety Software Market Size Study by Functionality, by Delivery Mode (On Premise & On Demand/Cloud based), by End User & by Region - Global Forecast 2018- 2025
    Date: 22 Aug, 2018
    Type:
    Pages: 80
    Geography: U.S. Canada UK Germany France China India Japan Brazil Mexico
    Code: 1000025
    Delivery Timeline:
    Global Pharmacovigilance and Drug Safety Software Market to reach USD 265.2 billion by 2025.

    Global Pharmacovigilance and Drug Safety Software Market valued approximately USD 150.4 billion in 2016 is anticipated to grow with a healthy growth rate of more than 6.5% over the forecast Year.The global drug safety software market is divided into two segments on the basis of delivery mode, namely, on premise delivery mode and on-demand/cloud based (SaaS) delivery mode. This market is also divided into pharma and biotech companies, contract research organizations (CROs), business process outsourcing (BPO) firms, and other pharmacovigilance service providers on the basis of type of end user. Factors such as increasing incidence rates of adverse drug reactions (ADRs) and growing adoption of pharmacovigilance software by organizations such as CROs and BPOs are driving the growth of the global pharmacovigilance software market.
    Manufacturers are now striving to identify various ways of cost reduction and minimizing operational expenses by gradually shifting from being fully integrated pharmaceutical companies to sharing costs by collaborating with service providers. Outsourcing helps increase internal resource flexibility, improves timelines, and results in better outcomes in short as well as long terms. Outsourcing also helps achieve better pharmacovigilance (PV) through regulatory compliance, higher quality, better productivity, and improved strategic outcomes. PV service providers, in an attempt to ensure sustainability, are providing customized and end-to-end solutions to meet consumer needs.
    The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

    By Functionality:

    • Adverse Event Reporting Software
    • Drug Safety Audits Software
    • Issue Tracking Software
    • Fully Integrated Software

    By Delivery Mode:
    • On-Premise
    • On-Demand/Cloud Based

    By End User:
    • Pharma and Biotech Companies
    • Contract Research Organizations (CROS)
    • Business Process Outsourcing (BPO) Firms


    By Regions:
    • North America
    • U.S.
    • Canada
    • Europe
    • UK
    • Germany
    • Asia Pacific
    • China
    • India
    • Japan
    • Latin America
    • Brazil
    • Mexico
    • Rest of the World

    Furthermore, years considered for the study are as follows:

    Historical year – 2015
    Base year – 2016
    Forecast period – 2017 to 2025
    Some of the key manufacturers involved in the market are- ArisGlobal, GMBH., Ennov., Oracle Corporation, Online Business Applications, Inc , Sarjen Systems Pvt. Ltd , Sparta Systems, Inc , United Bio source Corporation, Umbra Global & AB -Cube. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.

    Target Audience of the Global Pharmacovigilance and Drug Safety Software Market In Market Study:

    • Key Consulting Companies & Advisors
    • Large, medium-sized, and small enterprises
    • Venture capitalists
    • Value-Added Resellers (VARs)
    • Third-party knowledge providers
    • Investment bankers
    • Investors

    TABLE OF CONTENTS
    Chapter 1. Global Pharmacovigilance and Drug Safety Software Market Definition and Scope
    1.1. Research Objective
    1.2. Market Definition
    1.3. Scope of The Study
    1.4. Years Considered for The Study
    1.5. Currency Conversion Rates
    1.6. Report Limitation
    Chapter 2. Research Methodology
    2.1. Research Process
    2.1.1. Data Mining
    2.1.2. Analysis
    2.1.3. Market Estimation
    2.1.4. Validation
    2.1.5. Publishing
    2.2. Research Assumption
    Chapter 3. Executive Summary
    3.1. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
    3.2. Key Trends
    Chapter 4. Global Pharmacovigilance and Drug Safety Software Market Dynamics
    4.1. Growth Prospects
    4.1.1. Drivers
    4.1.2. Restraints
    4.1.3. Opportunities
    4.2. Industry Analysis
    4.2.1. Porter’s 5 Force Model
    4.2.2. PEST Analysis
    4.2.3. Value Chain Analysis
    4.3. Analyst Recommendation & Conclusion
    Chapter 5. Global Pharmacovigilance and Drug Safety Software Market, By Functionality
    5.1. Market Snapshot
    5.2. Market Performance - Potential Model
    5.3. Global Pharmacovigilance and Drug Safety Software Market, Sub Segment Analysis
    5.3.1. Adverse Event Reporting Software
    5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    5.3.2. Drug Safety Audits Software
    5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    5.3.3. Issue Tracking Software
    5.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    5.3.4. Fully Integrated Software
    5.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)



    Chapter 6. Global Pharmacovigilance and Drug Safety Software Market, By Delivery Mode
    6.1. Market Snapshot
    6.2. Market Performance - Potential Model
    6.3. Global Pharmacovigilance and Drug Safety Software Market, Sub Segment Analysis
    6.3.1. On Premise
    6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    6.3.2. On Demand / Cloud based
    6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

    Chapter 7. Global Pharmacovigilance and Drug Safety Software Market, By End User
    7.1. Market Snapshot
    7.2. Market Performance - Potential Model
    7.3. Global Pharmacovigilance and Drug Safety Software Market, Sub Segment Analysis
    7.3.1. Pharma and Biotech Companies
    7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    7.3.2. Contract Research Organizations (CROS)
    7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    7.3.3. Business Process Outsourcing (BPO) Firms
    7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)


    Chapter 8. Global Pharmacovigilance and Drug Safety Software Market, by Regional Analysis
    8.1. Global Pharmacovigilance and Drug Safety Software Market, Regional Market Snapshot (2015-2025)
    8.2. North America Global Pharmacovigilance and Drug Safety Software Market Snapshot
    8.2.1. U.S.
    8.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.2.1.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.2.1.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.2.1.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)



    8.2.2. Canada
    8.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.2.2.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.2.2.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.2.2.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)

    8.3. Europe Global Pharmacovigilance and Drug Safety Software Market Snapshot
    8.3.1. U.K.
    8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.1.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.1.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.1.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)


    8.3.2. Germany
    8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.2.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.2.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.2.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)

    8.3.3. France
    8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.3.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.3.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.3.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)


    8.3.4. Rest of Europe
    8.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.4.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.4.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.4.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)

    8.4. Asia Global Pharmacovigilance and Drug Safety Software Market Snapshot
    8.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.1.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.1.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.1.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)

    8.4.2. India
    8.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.2.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.2.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.2.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)

    8.4.3. Japan
    8.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.3.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.3.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.3.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)

    8.4.4. Rest of Asia Pacific
    8.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.4.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.4.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.4.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)

    8.5. Latin America Global Pharmacovigilance and Drug Safety Software Market Snapshot
    8.5.1. Brazil
    8.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.5.1.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.1.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.1.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)

    8.5.2. Mexico
    8.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.5.2.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.2.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.2.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)

    8.5.3. Rest of The World
    8.5.4. South America
    8.5.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.5.4.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.4.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.4.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)

    8.5.5. Middle East and Africa
    8.5.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.5.5.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.5.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.5.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)


    Chapter 9. Company Profiles
    9.1. Company Market Share (Subject to Data Availability)
    9.2. Top Market Strategies
    9.3. Company Profiles
    9.3.1. AB-Cube
    9.3.1.1. Overview
    9.3.1.2. Financial (Subject to Data Availability)
    9.3.1.3. Product Summary
    9.3.1.4. Recent Developments
    9.3.2. ArisGlobal
    9.3.3. Extedo GMBH.
    9.3.4. Ennov.
    9.3.5. Oracle Corporation
    9.3.6. Online Business Applications, Inc
    9.3.7. Sarjen Systems Pvt. Ltd
    9.3.8. Sparta Systems, Inc
    9.3.9. United Biosource Corporation
    9.3.10. Umbra Global
    TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET
    TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET
    TABLE 3. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET , REPORT SCOPE
    TABLE 4. YEARS CONSIDERED FOR THE STUDY
    TABLE 5. EXCHANGE RATES CONSIDERED
    TABLE 6. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET ESTIMATES & FORECASTS BY REGION 2015-2025 (USD BILLION)
    TABLE 7. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET ESTIMATES & FORECASTS BY COMPONENT 2015-2025 (USD BILLION)
    TABLE 8. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET ESTIMATES & FORECASTS BY TYPE 2015-2025 (USD BILLION)
    TABLE 9. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 10. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 11. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 12. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 13. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 14. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 15. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 16. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 17. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 18. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 19. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 20. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 21. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 22. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 23. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 24. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 25. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 26. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 27. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 28. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 29. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 30. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 31. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 32. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 33. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 34. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 35. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 36. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 37. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 38. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 39. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 40. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 41. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 42. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 43. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 44. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 45. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 46. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 47. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 48. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 49. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 50. CANADA GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 51. CANADA GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 52. CANADA GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 53. CANADA GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 54. CANADA GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 55. UK GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 56. UK GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 57. UK GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 58. UK GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 59. UK GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 60. GERMANY GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 61. GERMANY GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 62. GERMANY GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 63. GERMANY GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 64. GERMANY GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 65. ROE GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 66. ROE GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 67. ROE GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 68. ROE GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 69. ROE GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 70. CHINA GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 71. CHINA GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 72. CHINA GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 73. CHINA GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 74. CHINA GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 75. INDIA GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 76. INDIA GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 77. INDIA GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 78. INDIA GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 79. INDIA GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 80. JAPAN GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 81. JAPAN GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 82. JAPAN GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 83. JAPAN GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 84. JAPAN GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 85. ROAPAC GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 86. ROAPAC GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 87. ROAPAC GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 88. ROAPAC GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 89. ROAPAC GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 90. BRAZIL GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 91. BRAZIL GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 92. BRAZIL GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 93. BRAZIL GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 94. BRAZIL GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 95. MEXICO GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 96. MEXICO GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 97. MEXICO GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 98. MEXICO GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 99. MEXICO GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 100. ROLA GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 101. ROLA GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 102. ROLA GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 103. ROLA GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 104. ROLA GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 105. ROW GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 106. ROW GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 107. ROW GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 108. ROW GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 109. ROW GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    ?
    FIG 1. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET, RESEARCH METHODOLOGY
    FIG 2. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET, MARKET ESTIMATION TECHNIQUES
    FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
    FIG 4. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET, KEY TRENDS 2016
    FIG 5. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET, GROWTH PROSPECTS 2017-2025
    FIG 6. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET, PORTERS 5 FORCE MODEL
    FIG 7. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET, PEST ANALYSIS
    FIG 8. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET, VALUE CHAIN ANALYSIS
    FIG 9. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 10. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 11. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 12. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 13. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 14. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 15. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 16. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 17. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 18. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 19. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 20. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 21. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 22. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 23. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 24. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 25. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 26. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 27. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 28. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 29. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 30. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 31. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET, REGIONAL SNAPSHOT 2015 & 2025
    FIG 32. NORTH AMERICA GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET 2015 & 2025 (USD BILLON)
    FIG 33. EUROPE GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET 2015 & 2025 (USD BILLON)
    FIG 34. ASIA PACIFIC GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET 2015 & 2025 (USD BILLON)
    FIG 35. LATIN AMERICA GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET 2015 & 2025 (USD BILLON)
    FIG 36. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKETMARKET, COMPANY MARKET SHARE ANALYSIS (2016)
    AB-Cube

    ArisGlobal

    Extedo GMBH.

    Ennov.

    Oracle Corporation

    Online Business Applications, Inc

    Sarjen Systems Pvt. Ltd

    Sparta Systems, Inc

    United Biosource Corporation

    Umbra Global
    • Single User License
      $3,950.00
    • Enterprise Site License
      $5,550.00

    Why Us?

    Diligent Market mission is to provide "insight across the value chain" to help organizations make important business decisions through the use and analysis of actionable market intelligence. It is our mission to provide the most effective results and services coupled with acute client care to create a long-lasting relationship with our clients.